New York State Common Retirement Fund Sells 10,956 Shares of Masimo Co. (NASDAQ:MASI)

New York State Common Retirement Fund reduced its position in shares of Masimo Co. (NASDAQ:MASIFree Report) by 17.2% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 52,818 shares of the medical equipment provider’s stock after selling 10,956 shares during the period. New York State Common Retirement Fund’s holdings in Masimo were worth $4,631,000 at the end of the most recent quarter.

A number of other large investors also recently made changes to their positions in the company. National Bank of Canada FI bought a new stake in Masimo in the second quarter worth about $29,000. DHJJ Financial Advisors Ltd. bought a new stake in Masimo in the third quarter worth about $32,000. NBC Securities Inc. bought a new stake in Masimo in the third quarter worth about $34,000. Caisse DE Depot ET Placement DU Quebec bought a new stake in Masimo in the first quarter worth about $37,000. Finally, Massmutual Trust Co. FSB ADV raised its position in Masimo by 202.7% in the second quarter. Massmutual Trust Co. FSB ADV now owns 342 shares of the medical equipment provider’s stock worth $56,000 after acquiring an additional 229 shares during the period. 85.96% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Several analysts have commented on MASI shares. Wells Fargo & Company lowered their price objective on shares of Masimo from $110.00 to $81.00 and set an “equal weight” rating on the stock in a research report on Wednesday, November 8th. Raymond James lowered shares of Masimo from an “outperform” rating to a “market perform” rating in a research report on Wednesday, November 8th. Needham & Company LLC lowered shares of Masimo from a “buy” rating to a “hold” rating in a research report on Wednesday, January 3rd. Jefferies Financial Group reissued a “hold” rating and issued a $121.00 price target (up previously from $107.00) on shares of Masimo in a research report on Tuesday, January 30th. Finally, StockNews.com lowered shares of Masimo from a “hold” rating to a “sell” rating in a research report on Thursday, November 16th. One analyst has rated the stock with a sell rating, six have given a hold rating and one has issued a buy rating to the company. According to MarketBeat, Masimo has a consensus rating of “Hold” and a consensus price target of $121.86.

Check Out Our Latest Stock Analysis on Masimo

Masimo Price Performance

Shares of NASDAQ:MASI opened at $135.07 on Monday. The company has a 50 day moving average of $118.93 and a 200 day moving average of $105.00. The stock has a market cap of $7.14 billion, a P/E ratio of 82.36 and a beta of 0.97. Masimo Co. has a 12 month low of $75.22 and a 12 month high of $198.00. The company has a current ratio of 2.14, a quick ratio of 1.13 and a debt-to-equity ratio of 0.71.

About Masimo

(Free Report)

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and O3 regional oximetry.

Featured Articles

Want to see what other hedge funds are holding MASI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Masimo Co. (NASDAQ:MASIFree Report).

Institutional Ownership by Quarter for Masimo (NASDAQ:MASI)

Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.